These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs. Weckbecker G; Briner U; Lewis I; Bruns C Endocrinology; 2002 Oct; 143(10):4123-30. PubMed ID: 12239124 [TBL] [Abstract][Full Text] [Related]
23. Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis. Heiman ML; Murphy WA; Coy DH Neuroendocrinology; 1987 Jun; 45(6):429-36. PubMed ID: 2886933 [TBL] [Abstract][Full Text] [Related]
24. Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase. Epelbaum J; Enjalbert A; Krantic S; Musset F; Bertrand P; Rasolonjanahary R; Shu C; Kordon C Endocrinology; 1987 Dec; 121(6):2177-85. PubMed ID: 2890515 [TBL] [Abstract][Full Text] [Related]
25. Impaired suppression of growth hormone release by somatostatin in cultured adenohypophyseal cells of spontaneously diabetic BB/W rats. Welsh JB; Szabo M Endocrinology; 1988 Nov; 123(5):2230-4. PubMed ID: 2901949 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological activity of highly potent heptapeptide analogs of somatostatin with C-terminal modifications. Janecka A; Zubrzycka M Endocr Regul; 2001 Jun; 35(2):75-9. PubMed ID: 11563935 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin. Cai RZ; Szoke B; Lu R; Fu D; Redding TW; Schally AV Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1896-900. PubMed ID: 2869490 [TBL] [Abstract][Full Text] [Related]
28. Biological activity and receptor binding characteristics to various human tumors of acetylated somatostatin analogs. Pinski J; Milovanovic S; Yano T; Hamaoui A; Radulovic S; Cai RZ; Schally AV Proc Soc Exp Biol Med; 1992 May; 200(1):49-56. PubMed ID: 1349189 [TBL] [Abstract][Full Text] [Related]
29. A linear hexapeptide somatostatin antagonist blocks somatostatin activity in vitro and influences growth hormone release in rats. Baumbach WR; Carrick TA; Pausch MH; Bingham B; Carmignac D; Robinson IC; Houghten R; Eppler CM; Price LA; Zysk JR Mol Pharmacol; 1998 Nov; 54(5):864-73. PubMed ID: 9804621 [TBL] [Abstract][Full Text] [Related]
31. Characterization of pituitary membrane receptors for somatostatin in the rat. Srikant CB; Patel YC Endocrinology; 1982 Jun; 110(6):2138-44. PubMed ID: 6122562 [TBL] [Abstract][Full Text] [Related]
32. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone. Tannenbaum GS; Painson JC; Lengyel AM; Brazeau P Endocrinology; 1989 Mar; 124(3):1380-8. PubMed ID: 2563683 [TBL] [Abstract][Full Text] [Related]
33. Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity. Rivier J; Brazeau P; Vale W; Guillemin R J Med Chem; 1975 Feb; 18(2):123-6. PubMed ID: 1091734 [TBL] [Abstract][Full Text] [Related]
34. In vivo and in vitro effects of cholecystokinin octapeptide on the release of growth hormone in rats. Matsumura M; Yamanoi A; Yamamoto S; Mori H; Saito S Horm Metab Res; 1984 Dec; 16(12):626-30. PubMed ID: 6151935 [TBL] [Abstract][Full Text] [Related]
35. Tyrosylated analogues of somatostatin. Rivier JE; Brown MR; Vale WW J Med Chem; 1976 Aug; 19(8):1010-3. PubMed ID: 966246 [TBL] [Abstract][Full Text] [Related]
36. Synthesis of a nonreducible cyclic analog of somatostatin having only growth hormone release inhibiting activity. Garsky VM; Clark DE; Grant NH Biochem Biophys Res Commun; 1976 Dec; 73(4):911-6. PubMed ID: 15625860 [TBL] [Abstract][Full Text] [Related]
37. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor. Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164 [TBL] [Abstract][Full Text] [Related]
38. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures. Djordjijevic D; Zhang J; Priam M; Viollet C; Gourdji D; Kordon C; Epelbaum J Endocrinology; 1998 May; 139(5):2272-7. PubMed ID: 9564833 [TBL] [Abstract][Full Text] [Related]
39. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients. Lamberts SW; Oosterom R; Neufeld M; del Pozo E J Clin Endocrinol Metab; 1985 Jun; 60(6):1161-5. PubMed ID: 2860119 [TBL] [Abstract][Full Text] [Related]
40. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro. Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]